 Zidovudine natural history acquired immunodeficiency syndrome BACKGROUND METHODS trends survival persons acquired immunodeficiency syndrome AIDS relative effects natural history AIDS zidovudine use demographic clinical characteristics longitudinal observational population-based study data Maryland Human Immunodeficiency Virus Information System data base information Maryland AIDS Registry data public private health care claims vital statistics hospital long-term care ambulatory care records RESULTS median survival diagnosis persons AIDS days diagnoses diagnoses days persons AIDS April zidovudine available two-year survival men women persons years old persons non-Hispanic whites minorities persons category human immunodeficiency virus transmission homosexual contact heterosexual transfusion-related common modes transmission analyses groups survival likely zidovudine median survival zidovudine days days drug proportional-hazards analysis zidovudine therapy factor improved survival CONCLUSIONS Maryland residents AIDS improvement survival Zidovudine therapy aspects care improved survival